Načítá se...
IDH1 mutant negative ganglioglioma progression to gliosarcoma
Gangliogliomas comprise of less than 1% of all primary brain tumours. Malignant transformation is rare. Correspondingly, secondary gliosarcomas, especially in the absence of previous irradiation exposure is too, exceedingly rare. Recent evidence supports the use of mutant IDH1 testing in suspected a...
Uloženo v:
Hlavní autoři: | , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Elsevier
2017-09-01
|
Edice: | Interdisciplinary Neurosurgery |
On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2214751916300809 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|